PMX-53(Cat#: CTI-002)

This product is a potent C5a receptor antagonist, it inhibits C3aR with the IC50 of 20 nM. It is also a MrgX2 agonist and inhibits C5a-induced hypernociception in rats.

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

Summary Related Products & Services

Specifications
CAS No. 219639-75-5
Formula C47H65N11O7
Molecular Weight 896.1
Sequence FXPXWR (Modifications: Phe-1 = N-terminal Ac, X-2 = Orn, X-4 = D-Cha, Lactam bridge: Orn-2 to Arg-6 )
SMILES NC(=NCCCC1NC(=O)C(NC(=O)C(CC2CCCCC2)NC(=O)C2N(C(=O)C(CCCNC1=O)NC(=O)C(Cc1ccccc1)NC(=O)C)CCC2)Cc1c[nH]c2c1cccc2)N
IC50 IC50: 20nM
Purity 98%
Solubility H2O: 2 mg/ml
Storage Store at -20°C for short term; at -80 °C for long-term storage.
Target C5a
Introduction Complement component C5a, a type of anaphylatoxins, is one of the most potent effectors generated via cleavage of C5 molecule during complement activation. C5a binds two receptors, C5aR and C5L2. Most of the C5a functional effects occur by binding to C5aRs, a G-protein-coupled signaling receptor that has long been identified as an attractive drug target.
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry